Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (216)
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
13,196
Price
$37.11
Total Value
$489.70K
Shares Held After
413,563
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
4,241
Price
$37.77
Total Value
$160.18K
Shares Held After
137,101
% of Holdings
3.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
6,371
Price
$37.11
Total Value
$236.43K
Shares Held After
141,342
% of Holdings
4.3%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$5.84
Total Value
$243.33K
Shares Held After
1,816,448
% of Holdings
2.2%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$28.09
Total Value
$280.86K
Shares Held After
105,211
% of Holdings
8.7%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
4,835
Price
$2.47
Total Value
$11.94K
Shares Held After
198,205
% of Holdings
2.4%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
47,763
Price
$2.47
Total Value
$117.97K
Shares Held After
5,150,599
% of Holdings
0.9%
Opus Genetics, Inc. (IRD)
Jayagopal Ashwath — Chief Scientific & Dev. Ofc.
Shares
3,719
Price
$5.12
Total Value
$19.05K
Shares Held After
516,775
% of Holdings
0.7%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
3,719
Price
$5.25
Total Value
$19.53K
Shares Held After
300,781
% of Holdings
1.2%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
25,492
Price
$16.15
Total Value
$411.61K
Shares Held After
3,622
% of Holdings
87.6%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
24,438
Price
$5.21
Total Value
$127.33K
Shares Held After
1,750,855
% of Holdings
1.4%
BIOCRYST PHARMACEUTICALS INC (BCRX)
Barnes Alane P — Chief Legal Officer
Shares
150,000
Price
$9.15
Total Value
$1.37M
Shares Held After
400,703
% of Holdings
27.2%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
493
Price
$69.75
Total Value
$34.39K
Shares Held After
116,332
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
8,378
Price
$69.03
Total Value
$578.33K
Shares Held After
116,825
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
3,629
Price
$68.09
Total Value
$247.10K
Shares Held After
125,203
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Zaremba Rabourn Amy — Head of Fin. Quality Assurance
Shares
2,816
Price
$5.25
Total Value
$14.77K
Shares Held After
190,312
% of Holdings
1.5%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$15.16
Total Value
$90.96K
Shares Held After
2,112,777
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$15.16
Total Value
$227.40K
Shares Held After
2,118,777
% of Holdings
0.7%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$41.30
Total Value
$30.27K
Shares Held After
31,767
% of Holdings
2.3%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
72,276
% of Holdings
2.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
641
Price
$41.30
Total Value
$26.47K
Shares Held After
33,377
% of Holdings
1.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,177
Price
$41.94
Total Value
$49.36K
Shares Held After
34,018
% of Holdings
3.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,902
Price
$41.20
Total Value
$119.57K
Shares Held After
35,195
% of Holdings
7.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,921
Price
$40.11
Total Value
$117.16K
Shares Held After
38,097
% of Holdings
7.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$41.30
Total Value
$16.31K
Shares Held After
18,863
% of Holdings
2.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$41.30
Total Value
$24.78K
Shares Held After
236,984
% of Holdings
0.3%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
69,899
% of Holdings
2.5%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$41.30
Total Value
$71.41K
Shares Held After
927,309
% of Holdings
0.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
40,985
Price
$91.98
Total Value
$3.77M
Shares Held After
194,309
% of Holdings
17.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
18,864
% of Holdings
27.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
4,732
Price
$91.98
Total Value
$435.24K
Shares Held After
8,429
% of Holdings
36.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$90.76
Total Value
$181.52K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
16,515
Price
$91.98
Total Value
$1.52M
Shares Held After
40,272
% of Holdings
29.1%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
49,788
% of Holdings
12.8%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
475
Price
$9.29
Total Value
$4.41K
Shares Held After
16,525
% of Holdings
2.8%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,093
Price
$9.29
Total Value
$19.44K
Shares Held After
72,907
% of Holdings
2.8%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,770
Price
$47.30
Total Value
$131.03K
Shares Held After
288,976
% of Holdings
0.9%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
11,813
Price
$46.57
Total Value
$550.08K
Shares Held After
291,746
% of Holdings
3.9%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
894
Price
$9.29
Total Value
$8.31K
Shares Held After
32,687
% of Holdings
2.7%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
852
Price
$9.29
Total Value
$7.92K
Shares Held After
29,648
% of Holdings
2.8%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
10,349
Price
$48.26
Total Value
$499.44K
Shares Held After
245,834
% of Holdings
4.0%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
4,021
Price
$48.26
Total Value
$194.05K
Shares Held After
13,773
% of Holdings
22.6%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
5,848
Price
$48.26
Total Value
$282.22K
Shares Held After
17,794
% of Holdings
24.7%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
3,450
Price
$48.26
Total Value
$166.50K
Shares Held After
91,240
% of Holdings
3.6%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,150
Price
$48.26
Total Value
$152.02K
Shares Held After
13,143
% of Holdings
19.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$19.66
Total Value
$88.46K
Shares Held After
200,641
% of Holdings
2.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
8,000
Price
$19.66
Total Value
$157.26K
Shares Held After
205,141
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$537.37
Total Value
$85.98K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
763
Price
$536.49
Total Value
$409.34K
Shares Held After
40,673
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,551
Price
$535.59
Total Value
$830.70K
Shares Held After
41,436
% of Holdings
3.6%
Showing 151–200 of 216 transactions (page 4 of 5)